U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. HESPAN (6% Hetastarch in 0.9% Sodium Chloride injection)
  1. Approved Blood Products

HESPAN (6% Hetastarch in 0.9% Sodium Chloride injection)

NDA Number: BN890105
Manufacturer: B. Braun Medical, Inc.
Product name: HESPAN® (6% Hetastarch in 0.9% Sodium Chloride injection)
Indication:

  •  Treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. In leukapheresis, HESPAN has also been shown to be safe and efficacious in improving the harvesting and increasing the yield of granulocytes by centrifugal means.

Product Information

Supporting Documents

Back to Top